Introduction
Candidemia is the most prevalent clinical invasive candida infection. Although it usually occurs in neutropenic patients, it has begun to be encountered in various patient groups in recent years and is at the forefront as a cause of nosocomial infections. In a study from the United States, fungi ranked fourth among the causes of circulatory infections (1) . Candidemia is associated with high morbidity and mortality rates in patients that stay in the hospital for the long term. Candidemia-associated mortality rate ranges between 10% and 49% (2) .
Candida reaches the blood circulation via three different routes: the gastrointestinal system, the urinary system, and intravascular catheters (3) . There are certain risk factors that facilitate the development of candidemia. These include gastrointestinal surgical intervention, presence of a central venous catheter, mechanical ventilation, total parenteral nutrition, burns, malignancy, hemodialysis, long-term intensive care unit stay, broadspectrum antibiotics, corticosteroid use, and Candida colonization in the oral mucosa (4) (5) (6) .
In the present study, we aimed to retrospectively evaluate mortality-associated risk factors in candidemia cases developed in our hospital.
Materials and methods

Patients and variables
Files of the patients whose blood cultures revealed Candida growth in the microbiology laboratory between 1 January 2009 and 31 December 2011 at the İstanbul Medeniyet University Göztepe Training and Research Hospital were retrospectively reviewed. Patient age and sex, reason for hospitalization, the clinic at which the patient stayed, underlying disease, history of past surgical intervention, duration of hospital stay, time to Candida growth in blood culture, use of antifungal agent, and prognosis were derived from the patient files and recorded.
For isolation and identification of Candida from blood culture, cultures that gave a positive signal in the automatized blood culture system (BacT/Alert 3D 120, BioMerieux, France) were transferred onto blood agar and Endo agar. The agars on which transfer was performed were incubated at 37 °C for 24-48 h. The samples that showed growth were examined by Gram staining and typing was performed using a fungi identification kit (Candifast Es Twin, ELITech Microbio, France) for the samples that revealed yeast. Backward elimination was used for Cox regression analysis. Variables were tested in terms of collinearity and thereafter they were separately included into and excluded from the model and the final model was formed. Proportionality of variables and suitability of the final model were tested. Kaplan-Meier survival graphics were drawn and difference in survival function was assessed by log-rank test. Statistical significance was evaluated at P < 0.05 as two-sided.
Statistics
Results
Positive blood culture was detected in a total of 89 cases over the course of study period. While C. albicans was identified in 72% (64/89) and non-albicans Candida species were identified in 10% (9/89) of these cases, typing failed in 18% (16/89). C. parapsilosis was the most frequently isolated species among non-albicans Candida species. Solid organ tumors were present in six of the cases and none of these patients had been using chemotherapeutic agents at the time that candidemia was detected. Four patients were followed at the Department of Pediatric Hematology for febrile neutropenic episodes. No data were obtained from the records involving long-term use of agents that suppress the immune system, such as corticosteroids or tumor necrosis factor alpha inhibitors. Table 1 illustrates the distribution of candidemia cases among clinics and Table 2 illustrates characteristics of living and dead patients.
The crude mortality rate among cases was 30% (27/89). Of the patients with candidemia, 42% were over the age of 50 years and 63% were male. Staying in the intensive care unit and age (≥50 or ≥60) were found to be significant for mortality, particularly during univariate comparisons, whereas the multivariate model found that only the age of 50 years and over (OR = 2.7; CI = 1.05-6.73) was a significant risk factor for mortality. Statistical data are demonstrated by Cox regression analysis in Table 3 and by a Kaplan-Meier survival graphic in the Figure. 
Discussion
Candida species that cause candidemia show variation among countries and regions (7, 8) . Yapar et al. from Turkey conducted a study on candidemia and found the prevalence of C. albicans to be 75.7% and non-albicans to be 43.5%, but they reported that Candida species have increased in recent years (9) . In a study that evaluated 12-year candidemia cases in the Uludağ University Hospital of the Faculty of Medicine, C. albicans (45%) was found to be the leading agent, followed by C. parapsilosis (26%) (10) . A study from Spain reported an increase in nonalbicans Candida species, although the prevalence of C. albicans was found to be 51% and that of non-albicans species was found to be 49% (11) . Another study reported the most frequently isolated agents to be C. albicans (40%), C. parapsilosis (23%), C. glabrata (15%), C. tropicalis (9%), and other species (13%), respectively, from 182 Candida attacks in the intensive care unit. The same study emphasized that there is an increase in Candida species, which might have most significantly resulted from intensive use of azole prophylaxis in their unit (12) . In the candidemia cases investigated in the present study, the most frequently isolated agent was C. albicans (72%), followed by C. parapsilosis (9%), whereas C. krusei was isolated from a single case. Nevertheless, typing could not be performed for sixteen yeast cells. Our data show similarity to the data from both Turkey and European countries in terms of distribution of the species (8).
The literature contains numerous studies concerning the risk factors for the development of candidemia. It was demonstrated that long-term hospital stay and presence of a central venous catheter in a patient enhance the risk of developing candidemia (13). Barberino et al. determined the risk factors associated with candidemia to be the presence of a central venous catheter, total parenteral nutrition, broad-spectrum antibiotic use, and chronic renal insufficiency (14) . In a study from Thailand, staying in the intensive care unit was emphasized as a risk factor for developing candidemia (15) . Das et al. stated that broadspectrum antibiotic use, presence of intravascular catheter, staying in an intensive care unit, and history of surgical intervention are significant risk factors that influence the development of candidemia. Moreover, the same study determined that the risk of developing candidemia is higher in those having a history of gastrointestinal surgery as compared to other types of surgical interventions (16) . In a study carried out in medical and surgical intensive care units, it was emphasized that there was no relation between Candida species and risk factors that play a role in the development of candidemia, but that nonalbicans Candida was the most prevalent agent in those with a history of any surgical intervention, particularly gastrointestinal surgery (17) . Mortality rate shows variations among candidemia cases. Fraser et al. determined the mortality rate to be 57% and demonstrated that severity and prognosis of the underlying disease, duration of candidemia, and APACHE II score are closely associated with mortality (18) . It was emphasized that mortality rate is higher in non-albicans candidemia as compared to C. albicans in immunosuppressed and nonneutropenic patients staying in intensive care units (19) . In another study in the literature, it was stated that Candida species do not influence mortality (20) . In the present study, the most prevalent agent was C. albicans, with no statistically significant effect on mortality. It is known that commencing empirical antifungal therapy in the early period favorably influences the mortality rate. However, a study conducted in nonneutropenic patients determined no difference in mortality rate with early antifungal therapy (21) . A study from the United Kingdom demonstrated that neither empirical antifungal therapy nor treatment after positive blood culture significantly influenced the mortality rate (16) . In the present study, most of the patients did not receive empirical antifungal therapy. Antifungal therapy was commenced after blood culture positivity with no statistically significant difference in mortality rate. Erdem et al. demonstrated that candidemia-associated mortality rate was higher among patients staying in the intensive care unit. In addition, they explained that presence of a central venous catheter or urinary catheter did not influence the mortality rate in candidemia patients because all patients staying in the intensive care unit had invasive catheters (22) . In the present study, univariate comparisons revealed that staying in the intensive care unit is a significant factor for mortality, whereas the multivariate model determined no significant relation with mortality and only the age of 50 and over was found to be significantly correlated with mortality.
The most important limitation of this study is that the percentage of nonidentified species of Candida is very high and this may have affected the results of logistic regression analysis.
In conclusion, candidemia is a serious condition with high mortality. The risk of mortality is significantly higher particularly in patients at the age of 50 years and over and those staying in the intensive care unit. Therefore, candidemia should be considered in the differential diagnosis. Moreover, knowing local epidemiological trends of Candida species that are isolated from blood cultures would be a guide in choosing empirical antifungal agents. 
